Cancer Therapies: Technologies and Global Markets

Publication Date	May 2008
Publisher	BCC Research
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	BCC00215

Price

£3,320.00
approximately: $4,851 | €3,639

PDF

Order above formats by FAX

Summary

Study Objectives

Bcc's Goal In Conducting This Study Is To Provide An Overview Of The Current And Potential Aspects Of The Global Market For Cancer Therapies. The Report Determines The Market Size, Market Leaders, And Factors Affecting The Market For Cancer Therapies With The Inclusion Of The Market By Disease Sector.

The Overview Of Types Of Diseases And Different Therapies In Cancer Is Also Examined Along With Sale Figures Over The 5-Year Period From 2008 To 2013. Companies Manufacturing/Selling The Drugs To Treat Cancer Are Profiled, And The Factors Affecting Markets For These Products And How Those Markets Are Likely To Change Are Analyzed. Revenues Have Been Broken Down By The Type Of Therapies And By Different Regions.

Our Key Objective Is To Present A Comprehensive Analysis Of The Current And Future Market And To Analyze The Future Direction Of Cancer Therapies With An Emphasis On Newer Products.

Reasons For Doing This Study

Due To Continuous Technology Advances In Research And Development In The Field Of Oncology And The Requirement For Newer And More Effective Pharmaceutical Drugs/Therapies, Companies Are Investing In The Development Of These New Products To Lessen The Side Effects And Target The Disease. A Fundamental Change In Cancer Therapies Is Underway With A Shift From The Use Of Chemotherapy Drugs To Targeted Therapy Or The Use Of Chemotherapy Drugs Along With Targeted Therapies. Targeted Therapies Are Being Developed For Targeting Cancer Cells More Specifically. Targeted Therapies Are More Efficacious And Less Toxic Than Chemotherapy Due To Their More Selective Nature.

This Study Looks At Almost All Types Of Therapies/Products Used In Oncology. The Study Conducts The Prevalence Of Cancer Globally. The Research And Development Of New Products And Major Changes In Market Behavior Justify Focusing On This Segment. Finally, This Study Discusses The Usage Of These Drug Therapies By Disease Sector To Determine The Usage In Each Sector.

Contributions Of The Study And For Whom

The Study Contributes To The Areas Of Market Growth And Decline In Cancer Therapies From The Point Of View Of Manufacturers And Users. This Study Will Be Of Interest Largely To The Pharmaceutical And Biopharmaceutical Industries, Clinics, And Hospitals.

Scope Of The Study

The Scope Of This Study Encompasses The Markets For Cancer Therapies. Bcc Analyzes Each Market And Its Market Leaders; Different Types Of Therapies; The Prevalence Of Cancer; The Regulatory Environment; The Different Disease Sectors For Cancer; And Market Projections And Market Share. Technological Issues Include The Latest Trends And New Developments

Methodology

Both Primary And Secondary Sources Were Used For This Research. A Comprehensive Literature Search Was Conducted. The Literature Included Technical Newsletters And Journals As Well As Many Other Sources. The Data Were Collected Through Interviews And Correspondence With Various Pharmaceutical/Biotechnical Experts. Projections Were Based On Estimates Such As The Current Number Of End Users, Potential End Users, Likely Unit Prices, Rates Of Consumption, And Market Trends.

Information Sources

Bcc Surveyed Many Companies To Obtain Data For This Study. Included Were Manufacturers And End Users Of Cancer Drugs. We Gathered The Data; Spoke With Officials Of This Industry; And Reviewed Newsletters, Company Literature, Product Literature, A Host Of Technical Articles, Journals, Indexes, And Abstracts. Exhaustive Investigations Of Databases By Key Terminology Were Done. In Addition, We Compiled Data From Current Financial And Trade Information And Government Sources.

Content

Dawn Petershlc027b
Introduction
Study Objectives
Reasons For Doing This Study
Contributions Of The Study And For Whom
Scope Of The Study
Methodology
Information Sources
About The Author
Related Bcc Reports
Bcc Online Services
Disclaimer
Summary
Summary Table The Global Cancer Therapy Market, Through 2013 ($ Millions)
Summary Figure The Global Cancer Therapy Market, 2006-2013 ($ Millions)
Overview
What Is Cancer?
Causes Of Cancer
Types Of Cancer
Bladder Cancer
Risk Factors
Treatment
Breast Cancer
Risk Factors
Treatment
Treatment (Continued)
Colorectal Cancer
Risk Factors
Treatment
Endometrial Cancer
Risk Factors
Treatment
Kidney Cancer
Risk Factors
Treatment
Leukemia
Risk Factors
Treatment
Lung Cancer
Risk Factors
Treatment
Melanoma
Risk Factors
Treatment
Non-Hodgkins Lymphoma
Risk Factors
Treatment
Pancreatic Cancer
Risk Factors
Treatment
Prostate Cancer
Risk Factors
Treatment
Skin Cancer
Risk Factors
Treatment
Thyroid Cancer
Risk Factors
Treatment
Treatment (Continued)
Regulatory Issues
New Drug Approvals
Table Cancer Drugs Approved By The Fda
New Drug Applications
Table New Drug Applications (2005 To January 2008)
Recalls
Table Recalls (2005 To January 2008)
Prevalence
Worldwide Prevalence
Table Worldwide Prevalence Of Cancer, 2007 (Millions)
Table Worldwide Prevalence Of New Cases Of Cancer, By Region, 2007
Table Worldwide Deaths Due To Cancer, By Region, 2007
Prevalence In The United States
Table Estimated New Cancer Cases In The U.S., 2007
Table Cancer Deaths In The U.S., 2007
Prevalence In Europe
Table Estimated New Cancer Cases In Europe, 2007
Table Cancer Deaths In Europe, 2007
Classification Of Cancer Therapies
Chemotherapy
Alkylating And Alkylating-Like Agents
Table Alkylating Agents
Antimetabolites
Table Antimetabolites
Anthracyclines
Table Cytotoxic Antibiotic Drugs
Plant Alkaloids
Table Alkaloids/Mitotic Inhibitors
Topoisomerase Inhibitors
Table Topoisomerase Inhibitors
Biological Therapy Or Immunotherapy
Interferons And Other Cytokines
Table Interferons Used In Cancer Therapy
Table Interleukins Used In Cancer Therapy
Cancer Vaccines
Hormone Therapy
Antiestrogens
Table Antiestrogens Used In Cancer Therapy
Aromatase Inhibitor
Table Aromatase Inhibitors Used In The Treatment Of Cancer
Antiandrogens
Table Antiandrogens Used In Cancer Treatment
Luteinizing Hormone-Releasing Hormone
Table Luteinizing Hormone-Releasing Hormone Used In The Treatment Of Cancer
Targeted Therapy
Small Molecules/Cancer Growth Inhibitors
Table Cancer Growth Inhibitors
Monoclonal Antibodies
Conjugated
Naked
Table Monoclonal Antibodies Used In The Treatment Of Cancer
Industry Structure
Chemotherapy
Alkylating Agents
Table Shares Of Manufacturers/Distributors For Alkylating Agents, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Alkylating Agents, 2007 (%)
Anthracyclines
Table Shares Of Manufacturers/Distributors For Anthracyclines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Anthracyclines, 2007 (%)
Plant Alkaloids
Table Shares Of Manufacturers/Distributors For Plant Alkaloids, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Plant Alkaloids, 2007 (%)
Antimetabolites
Table Shares Of Manufacturers/Distributors For Antimetabolites, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antimetabolites, 2007 (%)
Topoisomerase
Table Shares Of Manufacturers/Distributors For Topoisomerase, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Topoisomerase, 2007 (%)
Market Leaders Of Chemotherapy
Table Worldwide Market Share In Chemotherapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Chemotherapy, 2007 (%)
Hormone Therapy
Antiestrogens
Table Shares Of Manufacturers/Distributors For Antiestrogens, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antiestrogens, 2007 (%)
Antiandrogens
Table Shares Of Manufacturers/Distributors For Antiandrogens, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antiendrogens, 2007 (%)
Aromatase Inhibitors
Table Shares Of Manufacturers/Distributors For Aromatase Inhibitors, 2007 (%)
Figure Shares Of Manufcaturers/Distributors For Aromatase Inhibitor, 2007 (%)
Lh-Rh Agonist Inhibitors
Table Shares Of Manufacturers/Distributors For Lh-Rh Agonist Inhibitors, 2007 (%)
Figure Shares Of Manufacturers/ Distributors For Lh Rh Agonist Inhibitors, 2007 (%)
Market Leaders Of Hormone Therapy
Table Worldwide Market Share In Hormone Therapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Hormone Therapy, 2007 (%)
Targeted Therapy
Monoclonal Antibodies
Table Shares Of Manufacturers/Distributors For Monoclonal Antibodies, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Monoclonal Antibodies, 2007 (%)
Small Molecules
Table Shares Of Manufacturers/Distributors For Small Molecules, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Small Molecules, 2007 (%)
Market Leaders Of Target Therapy
Table Worldwide Market Share In Target Therapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Target Therapy, 2007 (%)
Immunotherapy
Interferon And Cytokines
Table Shares Of Manufacturers/Distributors For Interferons And Cytokines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Interferons And Cytokines, 2007 (%)
Cancer Vaccines
Table Shares Of Manufacturers/Distributors For Cancer Vaccines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Cancer Vaccines, 2007 (%)
Market Leaders Of Immunotherapy
Table Worldwide Market Share In Immunotherapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Immunotherapy, 2007 (%)
Demand And Use
Factors Affecting Sales Of Cancer Drugs
Competition
Pricing/Cost
Major Factors For Future Growth
Life Expectancy
Patent Protection
Drug Portfolio Management
Significant Potential Of Developing Countries
Future Of The Cancer Market
Chemotherapy Will Sustain
Targeted Therapy Dominates
Patent Expiries
Strategies Of Big Pharmaceutical Companies
Enhancement In Production Capacity:
Market Strategy
Mergers, Acquisitions, And Collaborations
Further Investigations
Market Analysis
Chemotherapy
Chemotherapy
Market Size
Table Global Sales Of Drugs Used In Chemotherapy, Through 2013 ($ Millions)
Figure Global Sales Of Drugs Used In Chemotherapy, 2006-2013 ($ Millions)
Table Global Market Share Of Chemotherapy By Type, 2007 (%)
Figure Global Market Share Of Chemotherapy By Type, 2007 (%)
Alkylating Agents
Table Global Sales Of Alkylating Agents, Through 2013 ($ Millions)
Figure Global Sales Of Alkylating Agents, 2006-2013 ($ Millions)
Anthracyclines
Table Global Sales Of Anthracyclines, Through 2013 ($ Millions)
Figure Global Sales Of Anthracyclines, 2006-2013 ($ Millions)
Plant Alkaloids
Table Global Sales Of Plant Alkaloids, Through 2013 ($ Millions)
Figure Global Sales Of Plant Alkaloids, 2006-2013 ($ Millions)
Antimetabolites
Table Global Sales Of Antimetabolites, Through 2013 ($ Millions)
Figure Global Sales Of Antimetabolites, 2006-2013 ($ Millions)
Topoisomerase Inhibitors
Table Global Sales Of Topoisomerase Inhibitors, Through 2013 ($ Millions)
Figure Global Sales Of Topisomerase Inhibitors, 2006-2013 ($ Millions)
Hormone Therapy
Market Size
Table Global Sales Of Hormone Therapies, Through 2013 ($ Millions)
Figure Global Sales Of Hormone Therapies, 2006-2013 ($ Millions)
Table Global Share Of Hormone Therapy, By Type, 2007 (%)
Figure Global Share Of Hormone Therapy, By Type, 2007 (%)
Antiestrogens
Table Global Sales Of Antiestrogens, Through 2013 ($ Millions)
Figure Global Sales Of Antiestrogens, 2006-2013 ($ Millions)
Antiandrogens
Table Global Sales Of Antiandrogens, Through 2013 ($ Millions)
Figure Global Sales Of Antiandrogens, 2006-2013 ($ Millions)
Aromatase Inhibitors
Table Global Sales Of Aromatase Inhibitors, Through 2013 ($ Millions)
Figure Global Sales Of Aromatase Inhibitors, 2006-2013 ($ Millions)
Lh-Rh Agonists
Table Global Sales Of Lh-Rh Agonists, Through 2013 ($ Millions)
Figure Global Sales Of Lh-Rh Agonists, 2006-2013 ($ Millions)
Target Therapies
Market Size
Table Global Sales Of Target Therapy Cancer Products, Through 2013 ($ Millions)
Figure Worldwide Sales Of Target Therapy Cancer Products, 2006-2013 ($ Millions)
Table Global Share Of Targeted Therapy, By Type, 2007 (%)
Figure Global Share Of Target Therapy, By Type, 2007 (%)
Monoclonal Antibodies
Table Global Sales Of Monoclonal Antibodies, Through 2013 ($ Millions)
Figure Global Sales Of Monoclonal Antibodies, 2006-2013 ($ Millions)
Small Molecules
Table Global Sales Of Small Molecules, Through 2013 ($ Millions)
Figure Global Sales Of Small Molecules, 2006-2013 ($ Millions)
Immunotherapy
Market Size
Table Global Sales Of Immunotherapy Products, Through 2013 ($ Millions)
Figure Worldwide Sales Of Immunotherapy Products, 2006-2013 ($ Millions)
Table Global Revenue Share Of Immunotherapy By Type, 2007 (%)
Figure Global Share Of Immunotherpy, By Type, 2007 (%)
Interferons And Cytokines
Table Global Sales Of Interferons And Cytokines, Through 2013 ($ Millions)
Figure Global Sales Of Interferons And Cytokines, 2006-2013 ($ Millions)
Vaccines
Table Global Sales Of Cancer Vaccines, Through 2013 ($ Millions)
Figure Global Sales Of Cancer Vaccines, 2006-2013 ($ Millions)
New Developments
Table Cancer Drug Pipeline In Phase Iii Clinical Trials
Target
Table Cancer Drug Pipeline In Phase Clinical Trials
Table Cancer Drug Pipeline In Phase Clinical Trials
Market By Disease Type
Table Global Sales Of Cancer Therapy By Type Of Cancer, Through 2013 ($ Millions)
Figure Global Sales Of Cancer Therapy By Type Of Cancer, 2006-2013 ($ Millions)
Table Market Share Of Various Types Of Cancer, 2007 (%)
Figure Market Share Of Various Types Of Cancer, 2007 (%)
Breast Cancer Therapy
Table Sales And Market Share Of Various Therapies Used In Breast Cancer Treatment, 2007 ($ Million/%)
Figure Sales Of Various Therapies Used In Breast Cancer Treatment, 2007 ($ Millions)
Table Worldwide Market Share Of Companies For Breast Cancer Therapy Revenue, 2007 (%)
Figure Worldwide Market Share Of Companies For Breast Cancer Therapy Revenue, 2007 (%)
Colorectal Cancer
Table Sales And Market Share Of Various Therapies Used In Colorectal Cancer Treatment, 2007 ($ Million/%)
Figure Sales Of Various Therapies Used In Colorectal Cancer Treatment, 2007 ($ Millions)
Table Worldwide Market Share Of Companies In Colorectal Cancer Therapy Revenue, 2007 (%)
Figure Worldwide Market Share Of Companies In Colorectal Cancer Therapy Revenue, 2007 (%)
Prostate Cancer
Table Sales And Market Share Of Various Therapies Used In Prostate Cancer Treatment, 2007 ($ Million/%)
Figure Sales Of Various Therapies Used In Prostate Cancer Treatment, 2007 ($ Millions)
Table Worldwide Market Share Of Companies In Prostate Cancer Therapy Revenue, 2007 (%)
Figure Worldwide Market Share Of Companies In Prostate Cancer Therapy Revenue, 2007 (%)
Nonsmall Cell Lung Cancer
Table Global Sales And Market Share Of Various Therapies Used In Nonsmall Cell Lung Cancer Treatment, 2007 ($ Millions/%)
Figure Global Sales Of Various Therapies Used In Nonsmall Cell Lung Cancer Treatment, 2007 ($ Millions)
Table Global Market Share Of Companies In Non Small Cell Lung Cancer Therapy Revenue, 2007 (%)
Figure Worldwide Market Share Of Companies In Non Small Cell Lung Cancer Therapy Revenue, 2007 (%)
Head And Neck Cancer
Table Global Sales And Market Share Of Various Therapies Used In Head And Neck Cancer Treatment, 2007 ($ Million/%)
Figure Global Sales Of Various Therapies Used In Head And Neck Cancer Treatment, 2007 ($ Millions)
Table Worldwide Market Share Of Companies In Head And Neck Cancer Therapy Revenue, 2007 (%)
Figure Worldwide Market Share Of Companies In Head And Neck Cancer Therapy Revenue, 2007 (%)
Renal Cell Carcinoma
Table Global Sales And Market Share Of Various Therapies Used In Renal Cell Carcinoma Treatment, 2007 ($ Millions/%)
Figure Global Sales Of Various Therapies Used In Renal Cell Carcinoma Treatment, 2007 ($ Millions)
Table Global Market Share Of Companies In Renal Cell Carcinoma Therapy Revenue, 2007 (%)
Figure Global Market Share Of Companies In Renal Cell Carcinoma Therapy Revenue, 2007 (%)
Pancreatic Cancer Therapy
Table Global Sales And Market Share Of Various Therapies Used In Pancreatic Cancer Treatment, 2007 ($ Million/%)
Figure Global Sales Of Various Therapies Used In Pancreatic Cancer Treatment, 2007 ($ Millions)
Table Global Market Share Of Companies In Pancreatic Cancer Therapy Revenue, 2007 (%)
Figure Global Market Share Of Companies In Pancreatic Cancer Therapy Revenue, 2007 (%)
Patent Analysis
Total Patents
Patents By Year
Table Total Number Of Patents In Each Year, 2005-2008
Figure Number Of Patents, 2005-2008
Patents By Type
Table Number Of Patents By Type, 2005-2008
Figure Number Of Patents By Type, 2005-2008 (No. Of Patents)
Figure Number Of Patents, Share By Type, 2005-2008 (%)
Patents By Country
Table Total Number Of Patents By Country, 2005-2008
Patents By Company
Table Number Of Patents By Company, 2005-2008
Patents By Assignee
Table Number Of Patents By Asignee, 2005-2008
Company Profiles
Abraxis Biosciences, Inc.
Amgen Inc.
Astrazeneca Plc
Biogen Idec
Bristol-Myers Squibb
Celgene Corp.
Cephalon Inc.
Chugai Pharmaceutical Co., Ltd.
Eli Lilly And Co.
Genentech Inc.
Genentech Inc.
Genzyme Corp.
Glaxosmithkline Plc
Gpc Biotech Ag
Imclone Systems, Inc.
Infinity Pharmaceuticals, Inc.
Merck & Co.
Novartis
Osi Pharmaceuticals, Inc.
Pfizer Inc.
Progen Pharmaceuticals, Ltd.
Roche
Sanofi-Aventis
Schering-Plough
Seattle Genetics, Inc.
Tap Pharmaceutical Products, Inc.
Taiho Pharmaceuticals Co., Ltd.
Wyeth
Ym Biosciences, Inc.
Appendix
Appendix
Appendix
Summary Table The Global Cancer Therapy Market, Through 2013 ($ Millions)
Table Cancer Drugs Approved By The Fda
Table New Drug Applications (2005 To January 2008)
Table Recalls (2005 To January 2008)
Table Worldwide Prevalence Of Cancer, 2007 (Millions)
Table Worldwide Prevalence Of New Cases Of Cancer, By Region, 2007
Table Worldwide Deaths Due To Cancer, By Region, 2007
Table Estimated New Cancer Cases In The U.S., 2007
Table Cancer Deaths In The U.S., 2007
Table Estimated New Cancer Cases In Europe, 2007
Table Cancer Deaths In Europe, 2007
Table Alkylating Agents
Table Antimetabolites
Table Cytotoxic Antibiotic Drugs
Table Alkaloids/Mitotic Inhibitors
Table Topoisomerase Inhibitors
Table Interferons Used In Cancer Therapy
Table Interleukins Used In Cancer Therapy
Table Antiestrogens Used In Cancer Therapy
Table Aromatase Inhibitors Used In The Treatment Of Cancer
Table Antiandrogens Used In Cancer Treatment
Table Luteinizing Hormone-Releasing Hormone Used In The Treatment Of Cancer
Table Cancer Growth Inhibitors
Table Monoclonal Antibodies Used In The Treatment Of Cancer
Table Shares Of Manufacturers/Distributors For Alkylating Agents, 2007 (%)
Table Shares Of Manufacturers/Distributors For Anthracyclines, 2007 (%)
Table Shares Of Manufacturers/Distributors For Plant Alkaloids, 2007 (%)
Table Shares Of Manufacturers/Distributors For Antimetabolites, 2007 (%)
Table Shares Of Manufacturers/Distributors For Topoisomerase, 2007 (%)
Table Worldwide Market Share In Chemotherapy, 2007 (%)
Table Shares Of Manufacturers/Distributors For Antiestrogens, 2007 (%)
Table Shares Of Manufacturers/Distributors For Antiandrogens, 2007 (%)
Table Shares Of Manufacturers/Distributors For Aromatase Inhibitors, 2007 (%)
Table Shares Of Manufacturers/Distributors For Lh-Rh Agonist Inhibitors, 2007 (%)
Table Worldwide Market Share In Hormone Therapy, 2007 (%)
Table Shares Of Manufacturers/Distributors For Monoclonal Antibodies, 2007 (%)
Table Shares Of Manufacturers/Distributors For Small Molecules, 2007 (%)
Table Worldwide Market Share In Target Therapy, 2007 (%)
Table Shares Of Manufacturers/Distributors For Interferons And Cytokines, 2007 (%)
Table Shares Of Manufacturers/Distributors For Cancer Vaccines, 2007 (%)
Table Worldwide Market Share In Immunotherapy, 2007 (%)
Table Global Sales Of Drugs Used In Chemotherapy, Through 2013 ($ Millions)
Table Global Market Share Of Chemotherapy By Type, 2007 (%)
Table Global Sales Of Alkylating Agents, Through 2013 ($ Millions)
Table Global Sales Of Anthracyclines, Through 2013 ($ Millions)
Table Global Sales Of Plant Alkaloids, Through 2013 ($ Millions)
Table Global Sales Of Antimetabolites, Through 2013 ($ Millions)
Table Global Sales Of Topoisomerase Inhibitors, Through 2013 ($ Millions)
Table Global Sales Of Hormone Therapies, Through 2013 ($ Millions)
Table Global Share Of Hormone Therapy, By Type, 2007 (%)
Table Global Sales Of Antiestrogens, Through 2013 ($ Millions)
Table Global Sales Of Antiandrogens, Through 2013 ($ Millions)
Table Global Sales Of Aromatase Inhibitors, Through 2013 ($ Millions)
Table Global Sales Of Lh-Rh Agonists, Through 2013 ($ Millions)
Table Global Sales Of Target Therapy Cancer Products, Through 2013 ($ Millions)
Table Global Share Of Targeted Therapy, By Type, 2007 (%)
Table Global Sales Of Monoclonal Antibodies, Through 2013 ($ Millions)
Table Global Sales Of Small Molecules, Through 2013 ($ Millions)
Table Global Sales Of Immunotherapy Products, Through 2013 ($ Millions)
Table Global Revenue Share Of Immunotherapy By Type, 2007 (%)
Table Global Sales Of Interferons And Cytokines, Through 2013 ($ Millions)
Table Global Sales Of Cancer Vaccines, Through 2013 ($ Millions)
Table Cancer Drug Pipeline In Phase Iii Clinical Trials
Table Cancer Drug Pipeline In Phase Clinical Trials
Table Cancer Drug Pipeline In Phase Clinical Trials
Table Global Sales Of Cancer Therapy By Type Of Cancer, Through 2013 ($ Millions)
Table Market Share Of Various Types Of Cancer, 2007 (%)
Table Sales And Market Share Of Various Therapies Used In Breast Cancer Treatment, 2007 ($ Million/%)
Table Worldwide Market Share Of Companies For Breast Cancer Therapy Revenue, 2007 (%)
Table Sales And Market Share Of Various Therapies Used In Colorectal Cancer Treatment, 2007 ($ Million/%)
Table Worldwide Market Share Of Companies In Colorectal Cancer Therapy Revenue, 2007 (%)
Table Sales And Market Share Of Various Therapies Used In Prostate Cancer Treatment, 2007 ($ Million/%)
Table Worldwide Market Share Of Companies In Prostate Cancer Therapy Revenue, 2007 (%)
Table Global Sales And Market Share Of Various Therapies Used In Nonsmall Cell Lung Cancer Treatment, 2007 ($ Million/%)
Table Global Market Share Of Companies In Non Small Cell Lung Cancer Therapy Revenue, 2007 (%)
Table Global Sales And Market Share Of Various Therapies Used In Head And Neck Cancer Treatment, 2007 ($ Million/%)
Table Worldwide Market Share Of Companies In Head And Neck Cancer Therapy Revenue, 2007 (%)
Table Global Sales And Market Share Of Various Therapies Used In Renal Cell Carcinoma Treatment, 2007 ($ Million/%)
Table Global Market Share Of Companies In Renal Cell Carcinoma Therapy Revenue, 2007 (%)
Table Global Sales And Market Share Of Various Therapies Used In Pancreatic Cancer Treatment, 2007 ($ Million/%)
Table Global Market Share Of Companies In Pancreatic Cancer Therapy Revenue, 2007 (%)
Table Total Number Of Patents In Each Year, 2005-2008
Table Number Of Patents By Type, 2005-2008
Table Total Number Of Patents By Country, 2005-2008
Table Number Of Patents By Company, 2005-2008
Table Number Of Patents By Asignee, 2005-2008
Summary Figure The Global Cancer Therapy Market, 2006-2013 ($ Millions)
Figure Shares Of Manufacturers/Distributors For Alkylating Agents, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Anthracyclines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Plant Alkaloids, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antimetabolites, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Topoisomerase, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Chemotherapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antiestrogens, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Antiendrogens, 2007 (%)
Figure Shares Of Manufcaturers/Distributors For Aromatase Inhibitor, 2007 (%)
Figure Shares Of Manufacturers/ Distributors For Lh Rh Agonist Inhibitors, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Hormone Therapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Monoclonal Antibodies, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Small Molecules, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Target Therapy, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Interferons And Cytokines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Cancer Vaccines, 2007 (%)
Figure Shares Of Manufacturers/Distributors For Immunotherapy, 2007 (%)
Figure Global Sales Of Drugs Used In Chemotherapy, 2006-2013 ($ Millions)
Figure Global Market Share Of Chemotherapy By Type, 2007 (%)
Figure Global Sales Of Alkylating Agents, 2006-2013 ($ Millions)
Figure Global Sales Of Anthracyclines, 2006-2013 ($ Millions)
Figure Global Sales Of Plant Alkaloids, 2006-2013 ($ Millions)
Figure Global Sales Of Antimetabolites, 2006-2013 ($ Millions)
Figure Global Sales Of Topisomerase Inhibitors, 2006-2013 ($ Millions)
Figure Global Sales Of Hormone Therapies, 2006-2013 ($ Millions)
Figure Global Share Of Hormone Therapy, By Type, 2007 (%)
Figure Global Sales Of Antiestrogens, 2006-2013 ($ Millions)
Figure Global Sales Of Antiandrogens, 2006-2013 ($ Millions)
Figure Global Sales Of Aromatase Inhibitors, 2006-2013 ($ Millions)
Figure Global Sales Of Lh-Rh Agonists, 2006-2013 ($ Millions)
Figure Worldwide Sales Of Target Therapy Cancer Products, 2006-2013 ($ Millions)
Figure Global Share Of Target Therapy, By Type, 2007 (%)
Figure Global Sales Of Monoclonal Antibodies, 2006-2013 ($ Millions)
Figure Global Sales Of Small Molecules, 2006-2013 ($ Millions)
Figure Worldwide Sales Of Immunotherapy Products, 2006-2013 ($ Millions)
Figure Global Share Of Immunotherpy, By Type, 2007 (%)
Figure Global Sales Of Interferons And Cytokines, 2006-2013 ($ Millions)
Figure Global Sales Of Cancer Vaccines, 2006-2013 ($ Millions)
Figure Global Sales Of Cancer Therapy By Type Of Cancer, 2006-2013 ($ Millions)
Figure Market Share Of Various Types Of Cancer, 2007 (%)
Figure Sales Of Various Therapies Used In Breast Cancer Treatment, 2007 ($ Millions)
Figure Worldwide Market Share Of Companies For Breast Cancer Therapy Revenue, 2007 (%)
Figure Sales Of Various Therapies Used In Colorectal Cancer Treatment, 2007 ($ Millions)
Figure Worldwide Market Share Of Companies In Colorectal Cancer Therapy Revenue, 2007 (%)
Figure Sales Of Various Therapies Used In Prostate Cancer Treatment, 2007 ($ Millions)
Figure Worldwide Market Share Of Companies In Prostate Cancer Therapy Revenue, 2007 (%)
Figure Global Sales Of Various Therapies Used In Nonsmall Cell Lung Cancer Treatment, 2007 ($ Millions)
Figure Worldwide Market Share Of Companies In Non Small Cell Lung Cancer Therapy Revenue, 2007 (%)
Figure Global Sales Of Various Therapies Used In Head And Neck Cancer Treatment, 2007 ($ Millions)
Figure Worldwide Market Share Of Companies In Head And Neck Cancer Therapy Revenue, 2007 (%)
Figure Global Sales Of Various Therapies Used In Renal Cell Carcinoma Treatment, 2007 ($ Millions)
Figure Global Market Share Of Companies In Renal Cell Carcinoma Therapy Revenue, 2007 (%)
Figure Global Sales Of Various Therapies Used In Pancreatic Cancer Treatment, 2007 ($ Millions)
Figure Global Market Share Of Companies In Pancreatic Cancer Therapy Revenue, 2007 (%)
Figure Number Of Patents, 2005-2008
Figure Number Of Patents By Type, 2005-2008 (No. Of Patents)
Figure Number Of Patents, Share By Type, 2005-2008 (%)